InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Alkermes plc.

ALKS Clue Score59
Ireland Fiscal year ends December CIK 0001520262 Results filed 3 Nov 2026
Add to watchlist

What the insiders did Mostly scheduled

Individual transactions

27
Insider
Date
Role
Action
Shares
Price
Amount
David Joseph Gaffin
3 Nov 2026
EVP, CLO, Alkermes, Inc.
Sold on a plan
2,035
$46.17
$93.96K
David Joseph Gaffin
2 Oct 2026
EVP, CLO, Alkermes, Inc.
Sold on a plan
2,034
$41.03
$83.46K
David Joseph Gaffin
3 Sep 2026
EVP, CLO, Alkermes, Inc.
Sold on a plan
2,034
$48.01
$97.65K
Christian Todd Nichols
17 Aug 2026
SVP, Chief Commercial Officer
Sold on a plan
664
$49.65
$32.97K
Christian Todd Nichols
17 Aug 2026
SVP, Chief Commercial Officer
Sold on a plan
6,912
$49.19
$339.97K
David Joseph Gaffin
3 Aug 2026
EVP, CLO, Alkermes, Inc.
Sold on a plan
2,034
$48.58
$98.81K
David Joseph Gaffin
6 Jul 2026
EVP, CLO, Alkermes, Inc.
Sold on a plan
2,034
$54.03
$109.90K
Christopher I Wright
12 Jun 2026
Director
Sold on a plan
2,000
$45.10
$90.20K
David Joseph Gaffin
4 Jun 2026
EVP, CLO, Alkermes, Inc.
Sold on a plan
2,034
$43.05
$87.56K
David Joseph Gaffin
4 May 2026
EVP, CLO, Alkermes, Inc.
Sold on a plan
2,034
$33.20
$67.53K
David Joseph Gaffin
6 Apr 2026
EVP, CLO, Alkermes, Inc.
Sold on a plan
2,034
$34.57
$70.32K
David Joseph Gaffin
3 Mar 2026
EVP, CLO, Alkermes, Inc.
Sold on a plan
2,034
$29.76
$60.53K
David Joseph Gaffin
2 Mar 2026
EVP, CLO, Alkermes, Inc.
Sold on a plan
2,034
$29.29
$59.58K
Christian Todd Nichols
2 Mar 2026
SVP, Chief Commercial Officer
Sold on a plan
6,000
$30.00
$180.00K
Samuel Joseph Parisi
2 Mar 2026
VP, Finance (Interim PAO)
Sold on a plan
6,890
$29.29
$201.81K
Craig C. Hopkinson
2 Jan 2026
EVP R&D, Chief Medical Officer
Sold on a plan
4,000
$28.00
$112.00K
Craig C. Hopkinson
1 Dec 2025
EVP R&D, Chief Medical Officer
Sold on a plan
4,000
$29.30
$117.20K
Christian Todd Nichols
10 Jun 2025
SVP, Chief Commercial Officer
Sold on a plan
3,334
$31.09
$103.65K
Christian Todd Nichols
9 Jun 2025
SVP, Chief Commercial Officer
Sold on a plan
3,333
$31.95
$106.49K
Samuel Joseph Parisi
28 Feb 2025
VP, Finance (Interim PAO)
Sold on a plan
1,938
$34.00
$65.89K
Samuel Joseph Parisi
25 Feb 2025
VP, Finance (Interim PAO)
Sold on a plan
3,743
$35.26
$131.98K
Samuel Joseph Parisi
20 Feb 2025
VP, Finance (Interim PAO)
Sold on a plan
1,327
$35.69
$47.36K
Craig C. Hopkinson
5 Dec 2024
EVP R&D, Chief Medical Officer
Sold on a plan
9,221
$31.50
$290.46K
Craig C. Hopkinson
4 Dec 2024
EVP R&D, Chief Medical Officer
Sold on a plan
14,349
$30.77
$441.55K
Christian Todd Nichols
27 Nov 2024
SVP, Chief Commercial Officer
Sold on a plan
5,208
$29.15
$151.81K
Craig C. Hopkinson
6 Nov 2024
EVP R&D, Chief Medical Officer
Sold on a plan
10,471
$29.53
$309.17K
Christian Todd Nichols
18 Mar 2024
SVP, Chief Commercial Officer
Sold on a plan
10,417
$28.10
$292.74K
Showing 250 of 294 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 652
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 27
Sales straight out of an exercise 221
Sales at will 13
Transactions with no price 0
Shares from compensation/vesting 9,435,935
Sales filed before the plan box existed 12
History held since 20 Sep 2011